optical mapping
Bionano Genomics' Chinese Partner Nabs NMPA Approval for Saphyr OGM Platform
With the approval, Bionano's OEM partner Hangzhou Diagens Biotechnology can now sell the platform directly to hospitals and clinical labs in China.
Bionano Genomics Upbeat on Further Clinical Adoption of Optical Genome Mapping With New CPT Code
Premium
The Category I CPT code paves the way for reimbursement of OGM-based clinical tests, though details on pricing and insurance coverage are still unclear.
Bionano Genomics Inks OEM Deal With Chinese Partner to Commercialize Clinical Cytogenetics Workflow
Hangzhou Diagens Biotechnology has received China NMPA approval for Bionano's reagents and plans to register the Saphyr instrument for use in reproductive health.
Bionano Genomics' Chinese OEM Partner Nabs NMPA Approval for Sample Prep Products
Through its OEM partner A-smart MedTech, Bionano can now sell two more sample prep products for IVD applications in reproductive health in China.
Through its OEM partner, the company secured NMPA registrations for IVD use in China for its bone marrow aspirate DNA exaction kit and its DNA staining reagents.